Brief: Grey Wolf Therapeutics Reports Promising Preclinical Data From Research Collaboration With Immunocore

Immunocore Holdings

18/04/2023 12:12

April 18 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * GREY WOLF THERAPEUTICS REPORTS PROMISING PRECLINICAL DATA
FROM
RESEARCH COLLABORATION WITH IMMUNOCORE IN ORAL PRESENTATION AT
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL
MEETING 2023
    * IMMUNOCORE:FIRST-IN-CLASS ERAP1 INHIBITOR DRIVES IMPROVED
POTENCY & MAGNITUDE OF ANTI-TUMOUR ACTIVITY OF AN IMMUNOCORE TCR
BISPECIFIC IMMTAC THERAPY

Source text for Eikon:  ID:nPn2nBy7ra 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))